Santos C, Muñoz N, Klug S, Almonte M, Guerrero I, Alvarez M, Velarde C, Galdos O, Castillo M, Walboomers J, Meijer C, Caceres E
Instituto de Enfermedades Neoplásicas Dr Eduardo Cáceres Graziani, Av. Angamos Este 2520, Lima 34, Peru.
Br J Cancer. 2001 Sep 28;85(7):966-71. doi: 10.1054/bjoc.2001.1948.
We conducted a hospital-based case-control study in Peru of 198 women with histologically confirmed cervical cancer (173 squamous cell carcinomas and 25 cases of adenocarcinoma/adenosquamous carcinoma) and 196 control women. Information on risk factors was obtained by personal interview. Using PCR-based assays on exfoliated cervical cells and biopsy specimens, HPV DNA was detected in 95.3% of women with squamous cell carcinoma and in 92.0% of women with adenocarcinoma/adenosquamous carcinoma compared with 17.7% in control women. The age-adjusted odds ratio was 116.0 (95% Cl = 48.6-276.0) for squamous cell carcinoma and 51.4 (95% Cl = 11.4-232.0) for adenocarcinoma/adenosquamous carcinoma. The commonest types in women with cervical cancer were HPV 16, 18, 31, 52 and 35. The association with the various HPV types was equally strong for the two most common types (HPV 16 and 18) as for the other less common types. In addition to HPV, long-term use of oral contraceptives and smoking were associated with an increased risk. HPV is the main cause of both squamous cell carcinoma and adenocarcinoma in Peruvian women.
我们在秘鲁开展了一项基于医院的病例对照研究,研究对象为198名经组织学确诊为宫颈癌的女性(173例鳞状细胞癌和25例腺癌/腺鳞癌)以及196名对照女性。通过个人访谈获取风险因素信息。利用基于聚合酶链反应(PCR)的检测方法对脱落的宫颈细胞和活检标本进行检测,结果显示,鳞状细胞癌女性中95.3%检测到人乳头瘤病毒(HPV)DNA,腺癌/腺鳞癌女性中92.0%检测到HPV DNA,而对照女性中这一比例为17.7%。鳞状细胞癌的年龄调整优势比为116.0(95%可信区间=48.6 - 276.0),腺癌/腺鳞癌的年龄调整优势比为51.4(95%可信区间=11.4 - 232.0)。宫颈癌女性中最常见的HPV类型为16、18、31、52和35型。两种最常见的HPV类型(HPV 16和18)与其他较不常见类型相比,与各种HPV类型的关联强度相同。除HPV外,长期使用口服避孕药和吸烟也与风险增加有关。HPV是秘鲁女性鳞状细胞癌和腺癌的主要病因。